Skip to main content

Table 2 Baseline characteristics for the high risk patients who injected hCG (n = 353) and either developed (n = 40) or did not develop severe OHSS (n = 313)

From: Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study

 

N = 313 patients without severe OHSS

N = 40 patients with severe OHSS

p

Age (years)

32.6 ± 4.4

32.7 ± 4.0

0.960

BMI (kg/m2)

23.8 ± 4.8

24.8 ± 5.2

0.896

Duration of infertility (years)

3.8 ± 3.8

10.6 ± 1.4

0.958

Number of previous IVF attempts

1.1 ± 1.8

1.18 ± 1.93

0.084

Baseline FSH (IU/l)

6.7 ± 1.6

5.3 ± 1.4

0.008

Baseline LH(IU/l)

5.4 ± 2.5

5.6 ± 2.2

0.229

Baseline oestradiol (pg/ml)

32.9 ± 14.5

51.8 ± 27.0

0.652

Baseline progesterone (ng/ml)

0.51 ± 0.28

0.45 ± 0.23

0.157

Baseline TSH (mIU/ml)

1.7 ± 0.99

1.71 ± 0.92

0.763

Baseline prolactin (ng/ml)

16.7 ± 11.3

16.2 ± 10.5

0.566

  1. Values are expressed as mean ± standard deviation (SD) unless otherwise stated. P-values in bold depict statistical significance (p < 0.05).